US2019083683A1PendingUtilityA1
Implantable medical devices comprising bio-degradable alloys
Est. expiryJan 8, 2029(~2.5 yrs left)· nominal 20-yr term from priority
A61L 31/022A61B 17/8085A61F 2210/0004C22C 38/52A61B 17/866A61B 17/064C22C 38/48A61B 17/84C22C 38/04A61L 31/148A61F 2/82A61B 2017/00004A61C 8/0012C22C 38/50C22C 38/58C22C 38/44
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides medical devices comprising high-strength alloys which degrade over time in the body of a human or animal, at controlled degradation rates, without generating emboli. In one embodiment the alloy is formed into a bone fixation device such as an anchor, screw, plate, support or rod. In another embodiment the alloy is formed into a tissue fastening device such as staple. In yet another embodiment, the alloy is formed into a dental implant or a stent.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . An implantable medical device comprising a biodegradable alloy, wherein the alloy is substantially austenite in structure, and wherein the alloy has an average grain size in the range of about 0.5 microns to about 20 microns or a surface to volume ratio for individual grains of, on average, greater than 0.1 μ −1 .
2 . The implantable medical device of claim 1 , wherein the average grain size is about 0.5 microns to about 5.0 microns.
3 . The implantable medical device of claim 1 , wherein the average grain size is about 1.0 micron to about 2.0 microns.
4 . The implantable medical device of claim 1 , wherein the surface to volume ratio for individual grains is, on average, greater than 1.0 μ −1 .
5 . The implantable medical device of claim 1 , wherein the implantable device is a bone screw, bone anchor, tissue staple, craniomaxillofacial reconstruction plate, fastener, reconstructive dental implant, or stent.
6 . The implantable medical device of claim 1 , wherein the alloy comprises an austenite promoting component and a corrosion resisting component, and wherein the total amount of the austenite promoting component in the alloy is greater than about 10% and the total amount of the corrosion resisting component is about 0.5% to about 10%.
7 . The implantable medical device of claim 1 , wherein the alloy contains less than about 0.1% nickel and less than about 0.1% vanadium.
8 . The implantable medical device of claim 1 , wherein the alloy contains less than about 4% chromium.
9 . The implantable medical device of claim 1 , wherein the alloy contains less than about 6% cobalt.
10 . The implantable medical device of claim 1 , wherein the alloy contains less than about 0.1% nickel, less than about 0.1% vanadium, less than about 4% chromium, and less than about 6% of cobalt.
11 . The implantable medical device of claim 1 , wherein the alloy comprises an austenite promoting component comprising manganese, cobalt, platinum, palladium, iridium, aluminum, carbon, nitrogen, silicon, or any combination thereof, and wherein % platinum+% palladium+% iridium+0.5*(% manganese+% cobalt)+30*(% carbon+% nitrogen) is greater than about 12%.
12 . The implantable medical device of claim 1 , wherein the alloy comprises a corrosion resisting component comprising chromium, molybdenum, tungsten, tantalum, niobium, titanium, zirconium, hafnium, or any combination thereof, and wherein % chromium+% molybdenum+% tungsten+0.5*(% tantalum+% niobium)+2*(% titanium+% zirconium+% hafnium) is about 0.5% to about 7%.
13 . The implantable medical device of claim 1 , wherein the alloy comprises an austenite promoting component comprising manganese, cobalt, platinum, palladium, iridium, aluminum, carbon, nitrogen, silicon, or any combination thereof, wherein % platinum+% palladium+% iridium+0.5*(% manganese+% cobalt)+30*(% carbon+% nitrogen) is greater than about 12%, and wherein the alloy comprises a corrosion resisting component comprising chromium, molybdenum, tungsten, tantalum, niobium, titanium, zirconium, hafnium, or any combination thereof, wherein % chromium+% molybdenum+% tungsten+0.5*(% tantalum+% niobium)+2*(% titanium+% zirconium+% hafnium) is about 0.5% to about 7%.
14 . The implantable medical device of claim 1 , wherein the device is coated with a therapeutic agent.
15 . The implantable medical device of claim 1 , wherein the device is coated with a biodegradable hydrogel.
16 . The implantable medical device of claim 1 , wherein the device comprises a geometry that maximizes the surface to mass ratio.
17 . The implantable medical device of claim 1 , wherein the device comprises a hollow opening or passageway.
18 . An implantable medical device comprising a biodegradable alloy, wherein the alloy is substantially martensite in structure and comprises iron, carbon, a corrosion resisting component, and an austenite promoting component.
19 . The implantable medical device of claim 18 which contains about 65% to about 75% iron, about 0.1% to about 0.3% carbon, about 2.0% to about 6.0% of a corrosion resisting component, and about 20% to about 30% of an austenite promoting component.
20 . A container containing the implantable medical device of claim 1 and an instruction for using the implantable medical device for a medical procedure.
21 . A container containing the implantable medical device of claim 18 and an instruction for using the implantable medical device for a medical procedure.Join the waitlist — get patent alerts
Track US2019083683A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.